Medicine against gout reduces deaths in patients with Covid-19

A Canadian study mentions colchicine medicine as a way to reduce Covid-19 mortality.

Canadian investors will say that one medicine against the gut demonstrate its efficacy against covid-19.

Follow the study, the medicine 44% reduction in mortality and a 25% hospitalization. 4,488 patients were analyzed worldwide.

Spanish medicine is called colchicine or colchicine. It is a drug that is also used against arthritis and cirrhosis.

Según investigation del Montreal Cardio Institute (MHI), demonstrated “that the use of colchicine was associated with reductions in the risk of death”.

“In those patients with a diagnostic test of covid-19, colchicine reduce hospitalizations to 25%“, the need for mechanical ventilation at 50% and death at 44%”, added the authors.

The study was conducted with 4,488 patients of all Canada, United States, Europe, Suramerica and Surafrica.


Source